AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32188284 — intervention group
Group type: COMPARATOR
Intervention: Standard of care sutures (interrupted closure)
Number of subjects: 60
Study 34726144 — intervention group
Group type: EXPERIMENTAL
Intervention: High-in Warning Labels (HIWL)
Number of subjects: 22140
Study 34726144 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Star Ratings (HSR)
Number of subjects: 22140
Study 34726144 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline Daily Amounts (GDA)
Number of subjects: 22140
Study 34726144 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple Traffic Lights
Number of subjects: 22140
Study 34726144 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Warning Labels
Number of subjects: 22140
Study 34726144 — intervention group
Group type: COMPARATOR
Intervention: No label control
Number of subjects: 22140
Study 32324693 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated mobilization (staff dedicated to assist transfers and walking during hospital stay)
Number of subjects: 99
Study 32324693 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated mobilization
Number of subjects: 99
Study 32324693 — intervention group
Group type: COMPARATOR
Intervention: Usual care (preoperative education)
Number of subjects: 99
Study 33867254 — intervention group
Group type: EXPERIMENTAL
Intervention: NoGo-Alcohol
Number of subjects: 59
Study 33867254 — intervention group
Group type: EXPERIMENTAL
Intervention: NoGo-Neutral
Number of subjects: 59
Study 33867254 — intervention group
Group type: EXPERIMENTAL
Intervention: Go-Alcohol
Number of subjects: 59
Study 33867254 — intervention group
Group type: EXPERIMENTAL
Intervention: Go-Neutral
Number of subjects: 59
Study 33867254 — intervention group
Group type: EXPERIMENTAL
Intervention: N2 component
Number of subjects: 59
Study 33867254 — intervention group
Group type: EXPERIMENTAL
Intervention: P3 component
Number of subjects: 59
Study 34847900 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling with hope therapy (8 sessions of 45 minutes, twice a week)
Number of subjects: 52
Study 36032228 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared Decision Making (SDM) training program for clinicians based on the Japanese MDD guidelines
Number of subjects: 124
Study 36032228 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 124
Study 33377898 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote intensive management (RIM) by allied health care practitioners
Number of subjects: 301
Study 33377898 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote intensive management (RIM)
Number of subjects: 301
Study 32395828 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-week practice (TWP)
Number of subjects: 15
Study 32395828 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week practice (EWP)
Number of subjects: 15
Study 32395828 — intervention group
Group type: COMPARATOR
Intervention: Both groups (TWP and EWP)
Number of subjects: 15
Study 35440333 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening primrose vaginal capsule (500 mg) used vaginally, two doses
Number of subjects: 100
Study 35440333 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 33625502 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-delivered self-management intervention (self-help book and telephone-based peer counseling) in addition to care as usual (CAU)
Number of subjects: 89
Study 33625502 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 89
Study 33625502 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-delivered self-management intervention
Number of subjects: 89
Study 33461615 — intervention group
Group type: EXPERIMENTAL
Intervention: Consistent condom use during anal and vaginal intercourse
Number of subjects: 227
Study 33461615 — intervention group
Group type: COMPARATOR
Intervention: Any STI including HIV
Number of subjects: 227
Study 33461615 — intervention group
Group type: COMPARATOR
Intervention: Any STI except HIV
Number of subjects: 227
Study 33461615 — intervention group
Group type: COMPARATOR
Intervention: HIV
Number of subjects: 227
Study 33461615 — intervention group
Group type: COMPARATOR
Intervention: Chlamydia
Number of subjects: 227
Study 33461615 — intervention group
Group type: COMPARATOR
Intervention: Gonorrhea
Number of subjects: 227
Study 33461615 — intervention group
Group type: COMPARATOR
Intervention: Syphilis
Number of subjects: 227
Study 33461615 — intervention group
Group type: COMPARATOR
Intervention: Hepatitis B
Number of subjects: 227
Study 33461615 — intervention group
Group type: COMPARATOR
Intervention: Hepatitis C
Number of subjects: 227
Study 35116567 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 168
Study 35116567 — intervention group
Group type: COMPARATOR
Intervention: Micro-electroacupuncture (control)
Number of subjects: 168
Study 33292046 — intervention group
Group type: COMPARATOR
Intervention: Biomarkers measured using OLINK proximity extension assay panels and conventional immunoassays.
Number of subjects: 5607
Study 36030313 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrievable vena cava filters
Number of subjects: 223
Study 36030313 — intervention group
Group type: COMPARATOR
Intervention: Control group (no retrievable vena cava filters)
Number of subjects: 223
Study 36126255 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (5 mg)
Number of subjects: 84
Study 36126255 — intervention group
Group type: COMPARATOR
Intervention: Morphine (5 mg)
Number of subjects: 84
Study 36126255 — intervention group
Group type: COMPARATOR
Intervention: Morphine-Midazolam (5 mg each)
Number of subjects: 84
Study 33126555 — intervention group
Group type: COMPARATOR
Intervention: Physical Activity (PA)
Number of subjects: 155
Study 33126555 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity plus Weight Loss (PA + WL)
Number of subjects: 155
Study 34552033 — intervention group
Group type: EXPERIMENTAL
Intervention: Menthol-based topical analgesic
Number of subjects: 16
Study 35583116 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 days of antibiotics
Number of subjects: 106
Study 33184979 — intervention group
Group type: EXPERIMENTAL
Intervention: oral semaglutide (4-week dose escalation from 3 to 7 to 14 mg)
Number of subjects: 15
Study 33184979 — intervention group
Group type: EXPERIMENTAL
Intervention: oral semaglutide
Number of subjects: 15
Study 33184979 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 15
Study 34668923 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve replacement (TAVR)
Number of subjects: 0
Study 34668923 — intervention group
Group type: COMPARATOR
Intervention: Surgical aortic valve replacement (SAVR)
Number of subjects: 0
Study 33733955 — intervention group
Group type: EXPERIMENTAL
Intervention: Child-report ratings on psychosocial measures
Number of subjects: 200
Study 33733955 — intervention group
Group type: COMPARATOR
Intervention: Parent-report ratings on psychosocial measures
Number of subjects: 200
Study 33023067 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg/d algal DHA
Number of subjects: 957
Study 33023067 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 957
Study 35807852 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive mobile nutritional education for a year
Number of subjects: 203
Study 35807852 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 203
Study 34842540 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional voice
Number of subjects: 198
Study 34842540 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional voice (for women)
Number of subjects: 198
Study 34842540 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral voice (for men)
Number of subjects: 198
Study 34842540 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral face (for women)
Number of subjects: 198
Study 34842540 — intervention group
Group type: EXPERIMENTAL
Intervention: No face (voice-only black screen for men)
Number of subjects: 198
Study 34842540 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional voice (for men)
Number of subjects: 198
Study 34842540 — intervention group
Group type: COMPARATOR
Intervention: Neutral face and emotional face
Number of subjects: 198
Study 34369679 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS) applied to bilateral Hegu (LI4) and Quchi (LI11), once an hour, for 30 min each time, till the end of childbirth
Number of subjects: 198
Study 34369679 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS)
Number of subjects: 198
Study 34369679 — intervention group
Group type: COMPARATOR
Intervention: Control group (TEAS electrodes attached to the same acupoints without electric stimulation)
Number of subjects: 198
Study 34369679 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 198
Study 35128402 — intervention group
Group type: EXPERIMENTAL
Intervention: Nichi Glucan 0.5 g two times per day along with conventional treatment
Number of subjects: 18
Study 35128402 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment comprising remedial behavioural therapies and L‐carnosine 500 mg per day
Number of subjects: 18
Study 32033793 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart rate characteristics monitoring displayed
Number of subjects: 884
Study 32033793 — intervention group
Group type: COMPARATOR
Intervention: Heart rate characteristics monitoring not displayed (Control)
Number of subjects: 884
Study 35857132 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-strain probiotic (Lactobacillus acidophilus UBLA‐34, L. rhamnosus UBLR‐58, L. reuteri UBLRu‐87 (2 billion CFU each), L. plantarum UBLP‐40, L. casei UBLC‐42, L. fermentum UBLF‐31, Bifidobacterium bifidum UBBB‐55 (1 billion CFU each) and fructo‐oligosaccharides (100 mg)) along with dietary and lifestyle modifications
Number of subjects: 104
Study 35857132 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-strain probiotic along with dietary and lifestyle modifications
Number of subjects: 104
Study 35725626 — intervention group
Group type: EXPERIMENTAL
Intervention: Spotlight Consultations pre-clinic assessment
Number of subjects: 200
Study 34164808 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival rates at 1 year, 3 years, and 5 years for patients with CRC across all registries combined.
Number of subjects: 1707
Study 34164808 — intervention group
Group type: EXPERIMENTAL
Intervention: Relative survival at 5 years for patients with CRC.
Number of subjects: 1707
Study 34164808 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with poorer survival.
Number of subjects: 1707
Study 32490570 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumor debulking followed by chemotherapy
Number of subjects: 88
Study 32490570 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment with chemotherapy
Number of subjects: 88
Study 35292397 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-release bilayer tablets containing sarpogrelate HCl
Number of subjects: 0
Study 35292397 — intervention group
Group type: COMPARATOR
Intervention: Placebo layer
Number of subjects: 0
Study 36045227 — intervention group
Group type: EXPERIMENTAL
Intervention: 22G crown-cut needle
Number of subjects: 30
Study 36045227 — intervention group
Group type: COMPARATOR
Intervention: Conventional 22G needle
Number of subjects: 30
Study 34951464 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextroamphetamine (oral; 0.43 mg/kg)
Number of subjects: 20
Study 34951464 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 32382551 — intervention group
Group type: EXPERIMENTAL
Intervention: anti-VEGF treatment (ProReNata approach)
Number of subjects: 51
Study 35583486 — intervention group
Group type: EXPERIMENTAL
Intervention: Ratanasampil (RNSP)
Number of subjects: 108
Study 35583486 — intervention group
Group type: COMPARATOR
Intervention: Flunarizine (FLZ)
Number of subjects: 108
Study 35583486 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study 33455753 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated device (AMD alerts provided to farm personnel)
Number of subjects: 610
Study 33455753 — intervention group
Group type: COMPARATOR
Intervention: Control (AMD alerts not provided to farm personnel)
Number of subjects: 610
Study 33455753 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated device
Number of subjects: 610
Study 33455753 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 610
Study 33455753 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical disease without AMD alerts
Number of subjects: 610
Study 33455753 — intervention group
Group type: COMPARATOR
Intervention: Clinical disease with AMD alerts
Number of subjects: 610
Study 32272886 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-management by PCPs and nephrologists
Number of subjects: 242
Study 32272886 — intervention group
Group type: COMPARATOR
Intervention: Management by PCPs with written instructions and consultations by nephrologists on demand (standard care)
Number of subjects: 242
Study 32272886 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 242
Study 36404400 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirabegron (50 mg daily, titrated to 200 mg daily, n=39)
Number of subjects: 80
Study 36404400 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=41)
Number of subjects: 80
Study 33153929 — intervention group
Group type: COMPARATOR
Intervention: Conventional follow-up (arm A) with carcinoembryonic antigen, liver echography, and alternated lung radiography and CT scans
Number of subjects: 365
Study 33153929 — intervention group
Group type: EXPERIMENTAL
Intervention: PET/CT follow-up (arm B) every 6 months
Number of subjects: 365
Study 32643530 — intervention group
Group type: EXPERIMENTAL
Intervention: Softshell ankle brace (AE)
Number of subjects: 39
Study 32643530 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-rigid ankle brace (T1)
Number of subjects: 39
Study 32643530 — intervention group
Group type: COMPARATOR
Intervention: No braces
Number of subjects: 39
Study 35620165 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa (once per week intravenous)
Number of subjects: 95
Study 35620165 — intervention group
Group type: COMPARATOR
Intervention: Epoetin alfa (twice or three times per week intravenous)
Number of subjects: 95
Study 32130261 — intervention group
Group type: EXPERIMENTAL
Intervention: Meropenem
Number of subjects: 136
Study 32130261 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 136
Study 34940699 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole biomass of Phaeodactylum tricornutum (PT) at 5.3 g/day
Number of subjects: 22
Study 34940699 — intervention group
Group type: COMPARATOR
Intervention: Fish oil (FO) containing equal amounts of EPA and DHA (300 mg/day)
Number of subjects: 22
Study 34940699 — intervention group
Group type: COMPARATOR
Intervention: Sea fish at 185 g/week resulting in similar EPA and DHA intake
Number of subjects: 22
Study 32070847 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gum intervention
Number of subjects: 59
Study 32070847 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 59
Study 35795994 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehabilitation during neoadjuvant therapy
Number of subjects: 79
Study 35795994 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehabilitation with ≥75% adherence to exercise
Number of subjects: 79
Study 35795994 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehabilitation with increasing volumes of exercise
Number of subjects: 79
Study 35795994 — intervention group
Group type: COMPARATOR
Intervention: Loss of VAT during neoadjuvant therapy
Number of subjects: 79
Study 34371975 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced diet, PA, and sleep intervention
Number of subjects: 116
Study 34371975 — intervention group
Group type: COMPARATOR
Intervention: Pooled intervention group
Number of subjects: 116
Study 33973085 — intervention group
Group type: EXPERIMENTAL
Intervention: Transseptal sutures
Number of subjects: 180
Study 33973085 — intervention group
Group type: COMPARATOR
Intervention: Merocel packing
Number of subjects: 180
Study 33973085 — intervention group
Group type: COMPARATOR
Intervention: Silicone packing
Number of subjects: 180
Study 34181148 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone-paracetamol (OPT group)
Number of subjects: 232
Study 34181148 — intervention group
Group type: COMPARATOR
Intervention: Celecoxib (CEL group)
Number of subjects: 232
Study 33450060 — intervention group
Group type: EXPERIMENTAL
Intervention: 30‐min computer intervention
Number of subjects: 80
Study 33450060 — intervention group
Group type: COMPARATOR
Intervention: Usual curriculum waitlist (Control)
Number of subjects: 80
Study 32154123 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone extended-release (oral, flexibly dosed, 1.5‐12 mg/day)
Number of subjects: 324
Study 35260947 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial depression and adherence intervention
Number of subjects: 23
Study 35260947 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 23
Study 33248115 — intervention group
Group type: EXPERIMENTAL
Intervention: High-volume feeding (180-200 mL/kg/day)
Number of subjects: 86
Study 33248115 — intervention group
Group type: COMPARATOR
Intervention: Usual volume feeding (140-160 mL/kg/day)
Number of subjects: 86
Study 32993832 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of a package of noncommunicable disease interventions including cardiovascular risk scoring, hypertension management, and statin treatment.
Number of subjects: 0
Study 32993832 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused clinical training and support for primary health care providers.
Number of subjects: 0
Study 36225985 — intervention group
Group type: EXPERIMENTAL
Intervention: Bushen Huoxue Guchi recipe for 3 courses while basic periodontal treatment
Number of subjects: 60
Study 36225985 — intervention group
Group type: COMPARATOR
Intervention: Basic periodontal treatment without taking any drugs
Number of subjects: 60
Study 35065710 — intervention group
Group type: EXPERIMENTAL
Intervention: Daridorexant
Number of subjects: 0
Study 35065710 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32761109 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback-based oculomotor training (dichoptic feedback paradigm)
Number of subjects: 32
Study 35074136 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad26.COV2-S (Janssen)
Number of subjects: 1240
Study 35074136 — intervention group
Group type: EXPERIMENTAL
Intervention: BNT162b2 (Pfizer-BioNTech)
Number of subjects: 1240
Study 35074136 — intervention group
Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCoV-19 (AstraZeneca)
Number of subjects: 1240
Study 35074136 — intervention group
Group type: COMPARATOR
Intervention: CoronaVac (homologous boost)
Number of subjects: 1240
Study 34028130 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold therapy before amniocentesis (group 1)
Number of subjects: 480
Study 34028130 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold therapy after amniocentesis (group 2)
Number of subjects: 480
Study 34028130 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold therapy before and after amniocentesis (group 3)
Number of subjects: 480
Study 34028130 — intervention group
Group type: COMPARATOR
Intervention: Control group (group 4)
Number of subjects: 480
Study 34990968 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant clonidine (0.2 mg/d to a maximum of 0.6 mg/d)
Number of subjects: 70
Study 34990968 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 33369985 — intervention group
Group type: EXPERIMENTAL
Intervention: Volar Locking Plate (VLP)
Number of subjects: 156
Study 33369985 — intervention group
Group type: COMPARATOR
Intervention: External Fixation (EF)
Number of subjects: 156
Study 32878521 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus axitinib
Number of subjects: 0
Study 32878521 — intervention group
Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 0
Study 34328293 — intervention group
Group type: EXPERIMENTAL
Intervention: Klinefelter Syndrome (KS)
Number of subjects: 26
Study 34328293 — intervention group
Group type: EXPERIMENTAL
Intervention: Y chromosome microdeletions (Myc)
Number of subjects: 26
Study 34328293 — intervention group
Group type: EXPERIMENTAL
Intervention: CFTR gene mutations (CFTR)
Number of subjects: 26
Study 34328293 — intervention group
Group type: COMPARATOR
Intervention: Control group (obstructive azoospermia)
Number of subjects: 26
Study 34181875 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib
Number of subjects: 0
Study 34181875 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33561199 — intervention group
Group type: EXPERIMENTAL
Intervention: Surface area‐to‐volume ratio of culture medium, oil density, and oil thickness above the medium
Number of subjects: 107
Study 33561199 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-factor experiment with a combination of surface area‐to‐volume ratio, oil density, and oil thickness
Number of subjects: 107
Study 33561199 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeatability of identical treatments
Number of subjects: 107
Study 33561199 — intervention group
Group type: EXPERIMENTAL
Intervention: Final mathematical model
Number of subjects: 107
Study 35435813 — intervention group
Group type: EXPERIMENTAL
Intervention: OPT-IN tobacco treatment
Number of subjects: 1000
Study 35435813 — intervention group
Group type: COMPARATOR
Intervention: OPT-OUT tobacco treatment
Number of subjects: 1000
Study 35435813 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants who consented (n=741)
Number of subjects: 1000
Study 34143760 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with complicated surgical site infection (SSI)
Number of subjects: 535
Study 34143760 — intervention group
Group type: COMPARATOR
Intervention: Patients without surgical site infection (SSI)
Number of subjects: 535
Study 34143760 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with surgical site infection (SSI)
Number of subjects: 535
Study 32171749 — intervention group
Group type: EXPERIMENTAL
Intervention: Step-by-step video demonstration
Number of subjects: 43
Study 32171749 — intervention group
Group type: COMPARATOR
Intervention: Continuous video demonstration
Number of subjects: 43
Study 32171749 — intervention group
Group type: EXPERIMENTAL
Intervention: Step-by-step video demonstration (1 to 2 hours preparation)
Number of subjects: 43